Sign In
Buy KALV
$26.95
+0.0100 (+0.0371%)
At Close: Jun 03, 2026
Needham Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold - Markets
11:24am, Wednesday, 01'st Jul 2020
In a report released today, Serge Belanger from Needham downgraded Zynerba Pharmaceuticals (ZYNE – Research Report) to Hold. The company’s
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
11:00am, Wednesday, 01'st Jul 2020
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors today provided
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:13am, Wednesday, 01'st Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
12:00am, Wednesday, 01'st Jul 2020
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of
Analysts Are Bullish on These Healthcare Stocks: Verrica Pharmaceuticals (VRCA), Intercept Pharma (ICPT) - Markets
10:08am, Tuesday, 30'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Verrica Pharmaceuticals
Needham Assigns a Buy Rating on Zogenix (ZGNX) - Markets
10:00am, Monday, 29'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Zogenix (ZGNX – Research Report), with
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
12:34pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Aerie Pharma (AERI) Gets a Buy Rating from Needham - Markets
12:16pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report),
Hedge Funds Are Buying KalVista Pharmaceuticals, Inc. (KALV)
11:04pm, Tuesday, 23'rd Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Janus Henderson Group PLC Has $1.17 Million Holdings in Kalvista Pharmaceuticals Inc (NASDAQ:KALV)
07:26am, Tuesday, 23'rd Jun 2020
Janus Henderson Group PLC raised its position in Kalvista Pharmaceuticals Inc (NASDAQ:KALV) by 857.0% during the first quarter, according to the company in its most recent disclosure with the Securiti
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
01:00pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Needham Maintains a Buy Rating on Aerie Pharma (AERI) - Markets
12:55pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report),
Benzinga's Top Upgrades, Downgrades For June 15, 2020
01:57pm, Monday, 15'th Jun 2020
Upgrades * Berenberg changed the rating for Mondelez International Inc (NASDAQ: MDLZ) from Hold to Buy. For the first quarter, Mondelez International had an EPS of $0.69, compared to year-ago quarte
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on KalVista Pharmaceuticals
